Purchase Order 36C24626P0114
- Not listed
- The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 6 awarded a $47,775.00 firm-fixed-price purchase order contract to Biocartis US Inc., a for-profit organization, for the provision of the Biocartis Idylla instrument, EGFR assay, Idylla supplies, and other related medical and laboratory equipment and supplies. The contract has a completion date of April 30, 2024. This contract is not associated with a larger contract vehicle and does not...
- The U.S. Department of Veterans Affairs (VA) awarded a $14,220.00 firm fixed price purchase order to Biocartis US Inc., a foreign-owned for-profit organization, for FY25 Biocartis service agreement. The contract supports the provision of medical and laboratory equipment and supplies, primarily related to cancer research and diagnostics, including the Idylla instrument and related assays and reagents. The contract has no set-aside designation and will be performed in Asheville, North Carolina,...
- This is a $92,917.50 firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Biocartis US Inc., a large foreign-owned for-profit business, for Biocartis Idylla reagents and supplies. The contract supports the Asheville VA Medical Center's Pathology and Lab department in performing molecular testing of tumors and malignancies using the Biocartis Idylla system. The Idylla system allows the VA's pharmacists and oncologists to determine the best course of treatment...
- The U.S. Department of Veterans Affairs (VA) awarded a $441,828.09 firm-fixed-price purchase order contract to Biocartis US Inc. for the provision of Idylla instruments, EGFR assays, and related supplies and reagents. The contract is for the Veterans Integrated Service Network 22 (VISN 22) and has an ultimate completion date of August 25, 2026. The contract does not have a set-aside designation. Biocartis US Inc. is the prime contractor, and the contract does not indicate any major...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA VISN 16) awarded a $247,199.70 firm fixed price purchase order to Biocartis US Inc. for IDYLLA services. The contract has a one-year period of performance from July 1, 2023 through June 30, 2024. Biocartis US Inc. will deliver its IDYLLA molecular diagnostic testing platform and services from its location in Jersey City, New Jersey to support the VA - VHA VISN 16's healthcare...
- This federal contract award, valued at $116,829.71, was made by the U.S. Department of Veterans Affairs (VA) to Biocartis US Inc., a foreign-owned for-profit organization. The contract is for the supply of the Idylla molecular diagnostic testing platform, including instruments, assays, and reagents for cancer research and diagnostics. The contract was awarded without a small business set-aside and is a firm-fixed-price purchase order with a period of performance ending on May 15, 2027. The...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to Veterans Healthcare Supply Solutions Inc. for the delivery of BioCartis Idylla reagent assays. The solicitation requested quotes for six assay types totaling 142 packs from BioCartis US Inc. to be delivered to the Asheville VA Medical Center. Valued at $105,100, the contract has a period of performance of October 1, 2022 through...
- The U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 10 (VISN 10) awarded a $54,035.53 firm-fixed price purchase order contract to Biocartis US Inc., a foreign-owned for-profit organization, for a Biocartis Idylla Service Agreement at the Louis Stokes Cleveland VA Medical Center. This sole-source contract is for the provision of the Idylla molecular diagnostic testing platform, including instruments, assays, and reagents, to support cancer research and diagnostics at...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Biocartis US Inc., a foreign-owned, for-profit organization. The contract is for the procurement of MSI (microsatellite instability) testing reagent cartridges for the VA Greater Los Angeles Healthcare System's Pathology and Laboratory Medicine Services Department. The contract has a ceiling value of $62,361.00 and a performance period of January 31, 2027. This contract was awarded through...
- This is a federal contract award for $123,891.00 issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6) to Veterans Healthcare Supply Solutions, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB). The contract is for the purchase of QC Reagents and will be delivered to the Charles George VA Medical Center in Asheville, North Carolina. The contract period of performance runs from October 1, 2023, through November 20, 2024. The original...
The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 6, awarded a $42,660 firm-fixed-price purchase order to Biocartis US Inc. for the provision of a Biocartis Idylla service agreement at the Charles George VA Medical Center in Asheville, North Carolina. The contract, awarded on December 9, 2025, with an ultimate completion date of December 8, 2028, was awarded through full and open competition with no set-aside designation. Biocartis US Inc., a foreign-owned diagnostic technology company headquartered in Itasca, Illinois, specializes in molecular diagnostic platforms that provide rapid and automated testing capabilities for cancer-related diagnostics. The Biocartis Idylla platform supports the medical center's pathology and laboratory medicine operations by delivering advanced molecular diagnostic testing services, including microsatellite instability testing and EGFR assays for cancer marker identification. This service agreement aligns with the VA's mission to provide comprehensive cancer care and treatment planning for veteran patients by enabling healthcare professionals to access rapid molecular testing technologies that inform optimal therapeutic approaches. The award reflects Biocartis US Inc.'s demonstrated capability to provide specialized diagnostic equipment and related reagents to VA medical centers across multiple Veterans Integrated Service Networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 12/9/25 |